Literature DB >> 26101165

Being human: The role of pluripotent stem cells in regenerative medicine and humanizing Alzheimer's disease models.

Andrew A Sproul1.   

Abstract

Human pluripotent stem cells (PSCs) have the capacity to revolutionize medicine by allowing the generation of functional cell types such as neurons for cell replacement therapy. However, the more immediate impact of PSCs on treatment of Alzheimer's disease (AD) will be through improved human AD model systems for mechanistic studies and therapeutic screening. This review will first briefly discuss different types of PSCs and genome-editing techniques that can be used to modify PSCs for disease modeling or for personalized medicine. This will be followed by a more in depth analysis of current AD iPSC models and a discussion of the need for more complex multicellular models, including cell types such as microglia. It will finish with a discussion on current clinical trials using PSC-derived cells and the long-term potential of such strategies for treating AD.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Disease modeling; Regenerative medicine; Stem cell; iPSC

Mesh:

Year:  2015        PMID: 26101165     DOI: 10.1016/j.mam.2015.06.007

Source DB:  PubMed          Journal:  Mol Aspects Med        ISSN: 0098-2997


  11 in total

Review 1.  Stem cell therapies in age-related neurodegenerative diseases and stroke.

Authors:  Yuan Wang; Xunming Ji; Rehana K Leak; Fenghua Chen; Guodong Cao
Journal:  Ageing Res Rev       Date:  2016-11-19       Impact factor: 10.895

2.  The Alzheimer Disease-Causing Presenilin-1 L435F Mutation Causes Increased Production of Soluble Aβ43 Species in Patient-Derived iPSC-Neurons, Closely Mimicking Matched Patient Brain Tissue.

Authors:  Derek H Oakley; Mirra Chung; Naomi Klickstein; Caitlin Commins; Bradley T Hyman; Matthew P Frosch
Journal:  J Neuropathol Exp Neurol       Date:  2020-06-01       Impact factor: 3.685

Review 3.  Stem Cells and Natural Agents in the Management of Neurodegenerative Diseases: A New Approach.

Authors:  Aranka Brockmueller; Negin Mahmoudi; Amir Kian Movaeni; Anna-Lena Mueller; Abdol-Mohammad Kajbafzadeh; Mehdi Shakibaei; Masoumeh Majidi Zolbin
Journal:  Neurochem Res       Date:  2022-09-16       Impact factor: 4.414

4.  Efficient Derivation of Excitatory and Inhibitory Neurons from Human Pluripotent Stem Cells Stably Expressing Direct Reprogramming Factors.

Authors:  Saera Song; Archana Ashok; Damian Williams; Maria Kaufman; Karen Duff; Andrew Sproul
Journal:  Curr Protoc       Date:  2021-06

5.  BMS-708163 and Nilotinib restore synaptic dysfunction in human embryonic stem cell-derived Alzheimer's disease models.

Authors:  Hisae Nishioka; Norie Tooi; Takehisa Isobe; Norio Nakatsuji; Kazuhiro Aiba
Journal:  Sci Rep       Date:  2016-09-19       Impact factor: 4.379

6.  Mitophagy Failure in Fibroblasts and iPSC-Derived Neurons of Alzheimer's Disease-Associated Presenilin 1 Mutation.

Authors:  Patricia Martín-Maestro; Ricardo Gargini; Andrew A Sproul; Esther García; Luis C Antón; Scott Noggle; Ottavio Arancio; Jesús Avila; Vega García-Escudero
Journal:  Front Mol Neurosci       Date:  2017-09-14       Impact factor: 5.639

Review 7.  Modeling Human Neurological and Neurodegenerative Diseases: From Induced Pluripotent Stem Cells to Neuronal Differentiation and Its Applications in Neurotrauma.

Authors:  Hisham Bahmad; Ola Hadadeh; Farah Chamaa; Katia Cheaito; Batoul Darwish; Ahmad-Kareem Makkawi; Wassim Abou-Kheir
Journal:  Front Mol Neurosci       Date:  2017-02-28       Impact factor: 5.639

Review 8.  Regenerative Stem Cell Therapy for Neurodegenerative Diseases: An Overview.

Authors:  Farzane Sivandzade; Luca Cucullo
Journal:  Int J Mol Sci       Date:  2021-02-22       Impact factor: 5.923

Review 9.  A Dishful of a Troubled Mind: Induced Pluripotent Stem Cells in Psychiatric Research.

Authors:  Sára Kálmán; Edit Hathy; János M Réthelyi
Journal:  Stem Cells Int       Date:  2015-12-29       Impact factor: 5.443

10.  Alzheimer disease research in the 21st century: past and current failures, new perspectives and funding priorities.

Authors:  Francesca Pistollato; Elan L Ohayon; Ann Lam; Gillian R Langley; Thomas J Novak; David Pamies; George Perry; Eugenia Trushina; Robin S B Williams; Alex E Roher; Thomas Hartung; Stevan Harnad; Neal Barnard; Martha Clare Morris; Mei-Chun Lai; Ryan Merkley; P Charukeshi Chandrasekera
Journal:  Oncotarget       Date:  2016-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.